The concentration of IL-17 markedly reduced in the QCHS-treated DC group, whereas the mRNA and protein concentrations of IL-10 markedly increased in the QCHS-treated DC group compared with the experimental colitis model mice group (Fig. 3c and d). This evidence concerns the gene IL17A and colitis.